Skip to main content
Log in

No faint praise for tilt testing in vasovagal syncope

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Davis S, et al. Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury. Heart : 12 Dec 2012. Available from: URL: http://dx.doi.org/10.1136/heartjnl-2012-302851

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

No faint praise for tilt testing in vasovagal syncope. PharmacoEcon Outcomes News 670, 10 (2013). https://doi.org/10.1007/s40274-013-0108-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0108-0

Navigation